IN8bio, Inc. (INAB) Dividend History

IN8bio, Inc. (INAB) is a clinical-stage biotechnology company focused on developing innovative cell therapies for the treatment of resistant and hard-to-treat cancers. The company leverages its proprietary gamma delta T cell platform to engineer and enhance immune responses against tumors, aiming to improve patient outcomes through its advanced immunotherapy approaches.

Empire State Building, New York, NY, 10118
Phone: (646) 600-6438
Website: https://www.in8bio.com

Dividend History

IN8bio, Inc. currently does not pay dividends

Company News

  • IN8bio Recognizes Achievement of 4-Years in Remission for Patient Treated with INB-200 in Glioblastoma Trial

    IN8bio's gamma-delta T cell therapy INB-200 has demonstrated a significant clinical milestone, with a patient with a grade 4, IDH-mutant glioma remaining in remission and progression-free for 4 years after treatment. This outcome highlights the potential of INB-200 in treating this aggressive and deadly cancer.

    GlobeNewswire Inc.
  • Why PriceSmart Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket

    Shares of PriceSmart, Inc. (NASDAQ: PSMT) rose sharply in today’s pre-market trading as the company posted better-than-expected earnings for its second quarter. The company reported quarterly earnings of $1.31 per share, beating market estimates of $1.25 per share. PriceSmart’s quarterly sales came in at $1.29 billion versus expectations of $1.28 billion, according to data from Benzinga Pro. PriceSmart shares surged 4.6% to $86.90 in pre-market trading. Here are some other stocks moving in pre-market trading. Gainers Marin Software Incorporated (NASDAQ: MRIN) shares rose 76.1% to $0.5054 in pre-market trading after the company announced upgrades to its Microsoft Corp (NASDAQ: MSFT) advertising integration. iCoreConnect Inc. (NASDAQ: ICCT) shares rose 46.4% to $1.64 in pre-market trading. iCoreConnect, last month, closed $2,375,000 convertible note financing. Nano Labs Ltd (NASDAQ: NA) gained 35.1% to $2.00 in pre-market trading. Nano Labs recently filed annual report on Form 20-F for fiscal year 2023. IN8bio, Inc. (NASDAQ: INAB) shares gained 20.2% to $1.31 in pre-market trading after the company announced new preclinical data from its non-signaling gamma-delta ...

    Benzinga
    Featured Companies: ASTI DXYZ GLMD JAGX MRIN MSFT NA PRFX PSMT
  • Wall Street Breakfast: The Week Ahead

    Get the latest financial updates and insights with Wall Street Breakfast's daily podcast available on Seeking Alpha, iTunes, and Spotify.

    Seeking Alpha
    Featured Companies: ABM ACLX ACM ADBE AFRM AGIO AMT BASE BMY CASY CAVA CHWY CNC COST CRSP CRVS DDC DRI INCY INTC JBL JCI LEN LHX LLY ORCL PFE RIGL SDGR SGN SHIM STTK VOR WDFC WEC
  • Here's Why IN8bio, Inc. (INAB) Could be Great Choice for a Bottom Fisher

    IN8bio, Inc. (INAB) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

    Zacks Investment Research
  • Best Penny Stocks To Buy Today? 4 To Watch Under $5

    Penny stocks under $5 to watch this week. The post Best Penny Stocks To Buy Today? 4 To Watch Under $5 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    PennyStocks
    Featured Companies: ORMP PLX VMEO
Page data last updated 07/23/2025 16:09:59 UTC